Xeris Biopharma Inc.
XERS | NASDAQ
$8.81
+$0.01 (+0.11%)
Sep 22, 2026, 1:32 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 111.04M | 71.62M | 67.45M | 121.97M | 67.27M | 37.6M |
Short-Term Investments | n/a | n/a | 5M | n/a | 35.16M | 96.19M |
Long-Term Investments | n/a | 4.12M | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 5.22M | -4.81M | 4.54M | 4.73M | 829K | 232K |
Receivables | 51.05M | 40.42M | 39.2M | 30.83M | 17.46M | 6.88M |
Inventory | 68.67M | 48.18M | 38.84M | 24.74M | 18.12M | 8.35M |
Other Current Assets | 9.55M | 7.45M | 5.78M | 9.29M | n/a | n/a |
Total Current Assets | 240.31M | 167.66M | 156.26M | 186.82M | 142.6M | 152.21M |
Property-Plant & Equipment | 27.06M | 28.21M | 29.18M | 9.51M | 6.63M | 6.71M |
Goodwill & Intangibles | 110.94M | 121.78M | 132.62M | 143.47M | 154.31M | n/a |
Total Long-Term Assets | 143.21M | 155.4M | 166.34M | 157.7M | 161.77M | 6.94M |
Total Assets | 383.53M | 323.06M | 322.6M | 344.52M | 304.36M | 159.15M |
Account Payables | 3.08M | 2.29M | 11.57M | 4.61M | 8.92M | 3.12M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 6.23M | 15.1M | n/a | n/a | n/a | n/a |
Other Current Liabilities | 100.27M | 39.75M | 51.43M | 27.23M | 25.63M | 11.2M |
Total Current Liabilities | 109.57M | 100.44M | 95.19M | 73.62M | 79.04M | 28.21M |
Long-Term Debt | 31.53M | 217.01M | 190.93M | 187.08M | 88.07M | 87.02M |
Other Long-Term Liabilities | 228.73M | 1.97M | 6.23M | 25.72M | 37.08M | 10.16M |
Total Long-Term Liabilities | 260.26M | 252.23M | 234.19M | 225.71M | 130.09M | 97.18M |
Total Liabilities | 369.84M | 352.68M | 329.38M | 299.34M | 209.13M | 125.39M |
Total Debt | 37.76M | 271.45M | 229.19M | 198.06M | 88.07M | 87.02M |
Book Value | 13.69M | -29.62M | -6.78M | 45.19M | 95.23M | 33.76M |
Book Value Per Share | 0.08 | -0.20 | -0.05 | 0.33 | 1.21 | 0.79 |
Common Stock | 17K | 15K | 14K | 14K | 13K | 6K |
Retained Earnings | -671.31M | -671.86M | -617.03M | -554.77M | -460.11M | -337.39M |
Comprehensive Income | -25K | -25K | -25K | -23K | -31K | 6K |
Shareholders Equity | 13.69M | -29.62M | -6.78M | 45.19M | 95.23M | 33.76M |
Total Investments | n/a | 4.12M | 5M | n/a | 35.16M | 96.19M |
Add to Watchlist
Select watchlists to add or remove XERS